King Luther Capital Management Corp Neogenomics Inc Transaction History

King Luther Capital Management Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$7.06 - $13.97 $154,719 - $306,152	-21,915 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$12.15 - $35.28 $1.01 Million - $2.93 Million	-82,940 Reduced 79.1%	21,915 $266,000
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $654,010 - $1.04 Million	-21,450 Reduced 16.98%	104,855 $3.58 Million
Q3 2021 Nov 10, 2021	SELL	$41.66 - $52.52 $167,056 - $210,605	-4,010 Reduced 3.08%	126,305 $6.09 Million
Q2 2021 Aug 13, 2021	SELL	$36.62 - $51.69 $523,299 - $738,650	-14,290 Reduced 9.88%	130,315 $5.89 Million
Q1 2021 May 12, 2021	SELL	$41.56 - $59.88 $690,311 - $994,606	-16,610 Reduced 10.3%	144,605 $6.97 Million
Q4 2020 Feb 10, 2021	SELL	$36.08 - $56.47 $78,474 - $122,822	-2,175 Reduced 1.33%	161,215 $8.68 Million
Q3 2020 Nov 12, 2020	SELL	$33.26 - $40.48 $205,546 - $250,166	-6,180 Reduced 3.64%	163,390 $6.03 Million
Q2 2020 Aug 12, 2020	BUY	$24.21 - $31.02 $239,194 - $306,477	9,880 Added 6.19%	169,570 $5.25 Million
Q1 2020 May 13, 2020	SELL	$20.5 - $34.53 $212,790 - $358,421	-10,380 Reduced 6.1%	159,690 $4.41 Million
Q4 2019 Feb 12, 2020	BUY	$18.96 - $29.84 $206,284 - $324,659	10,880 Added 6.83%	170,070 $4.98 Million
Q3 2019 Nov 12, 2019	SELL	$19.12 - $26.24 $7,208 - $9,892	-377 Reduced 0.24%	159,190 $3.04 Million
Q2 2019 Aug 12, 2019	BUY	$19.57 - $24.1 $315,409 - $388,419	16,117 Added 11.24%	159,567 $3.5 Million
Q1 2019 May 10, 2019	BUY	$12.14 - $20.46 $1.74 Million - $2.93 Million	143,450 New	143,450 $2.94 Million

293

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.86B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on King Luther Capital Management Corp with notifications on news.